Merck & Co., Inc. — Director's Dealing 2014

Feb 13, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2014-02-11

Reporting Person: Schechter Adam H (EVP & Pres-Global Human Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-11	Common Stock	M	12500.0000	$48.2400	Acquired	12500.0000	Direct
2014-02-11	Common Stock	M	3000.0000	$45.4100	Acquired	15500.0000	Direct
2014-02-11	Common Stock	M	2500.0000	$47.3900	Acquired	18000.0000	Direct
2014-02-11	Common Stock	S	18000.0000	$55.6075	Disposed	0.0000	Direct
2014-02-11	Common Stock - 401(k) Plan	I	4040.3746	$55.7000	Disposed	0.0000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-11	Stock Option (right to buy)	$48.2400	M	12500.0000	Disposed	2014-02-26	Common Stock (12500.0000)	Direct
2014-02-11	Stock Option (right to buy)	$47.3900	M	2500.0000	Disposed	2014-05-02	Common Stock (2500.0000)	Direct
2014-02-11	Stock Option (right to buy)	$45.4100	M	3000.0000	Disposed	2014-08-01	Common Stock (3000.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	70507.9747	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.52 to $55.72, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.

F2: Includes 97.2259 shares acquired under the Merck U.S. Savings Plan, a 401(k) plan, since the date of the reporting person's last ownership report.

F3: Holdings include shares acquired in dividend reinvestment transactions.